Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest Articles A cross-sectional survey of relationship between serum TSH level and blood pressure
Journal of Human Hypertension, 06/29/09
Liu D et al. – The prevalence of hypertension in subclinical hypothyroidism group was significantly higher than in euthyroid group in females. Change of thyroid-stimulating hormone (TSH) in normal range did not affect blood pressure.
Methods- Study of the relationship between different levels of TSH and blood pressure in pts with subclinical hypothyroidism and euthyroidism
- Questionnaire survey for 1319 pts
- Measurements of blood pressure, height, and body weight
- Blood samples for serum TSH
- Assessment of FT3 and FT4 if abnormal TSH
- Pts classified as euthyroid group and subclinical hypothyroidism group
- Euthyroid group: group A (TSH 0.3–0.99 mIU l-1), group B (TSH 1.0–1.9 mIU l-1) and group C (TSH 1.91–4.8 mIU l-1)
- Different levels of serum TSH had no relation with systolic blood pressure (SBP) and diastolic blood pressure (DBP)
- Prevalence of hypertension in subclinical hypothyroidism group significantly higher than euthyroid group in females (41.3 vs 25.6%)
- Risk of hypertension in subclinical hypothyroidism group significantly higher than that in euthyroid group after adjusted for age, gender, smoking status, HOMA-IR (homoeostasis model assessment of insulin resistance) and body mass index
- Association stronger in females; no statistical significance in males
- Within normal range of TSH, both SBP and DBP similar among the 3 groups
- Prevalence and risk of hypertension also similar among the 3 groups
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/23/09
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Current options for the treatment of resistant hypertension
Expert Review of Cardiovascular Therapy , 11/13/09
Sponsor
Article Search
Sponsor
Sponsor